Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating hypertension in the elderly.

R W Schrier1

  • 1Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA.

The American Journal of Geriatric Cardiology
|October 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

VEGF receptor inhibition slows the progression of polycystic kidney disease.

Kidney international·2007
Same author

Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion.

Kidney international·2007
Same author

Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.

Alimentary pharmacology & therapeutics·2006
Same author

Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease.

Kidney international·2006
Same author

From finch to fish to man: role of aquaporins in body fluid and brain water regulation.

Neuroscience·2004
Same author

Water-losing and water-retaining states: role of water channels and vasopressin receptor antagonists.

Heart disease (Hagerstown, Md.)·2002

Hypertension is common in older adults, increasing cardiovascular disease risk. Effective treatment in the elderly requires careful drug selection due to unique health challenges.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Hypertension is highly prevalent in the elderly, a rapidly growing demographic.
  • Elevated blood pressure significantly increases cardiovascular disease (CVD) risk in older individuals.
  • Treating hypertension in the elderly is crucial for reducing CVD morbidity and mortality.

Purpose of the Study:

  • To review the challenges and considerations for antihypertensive therapy in elderly patients.
  • To highlight the importance of selecting appropriate medications for this population.

Main Methods:

  • Review of epidemiologic studies on hypertension in the elderly.
  • Analysis of factors complicating antihypertensive treatment in older adults.
  • Discussion of drug characteristics important for geriatric hypertension management.

Related Experiment Videos

Main Results:

  • Elderly individuals face unique challenges in hypertension management, including metabolic/physiologic changes, comorbidities, and polypharmacy.
  • Biologic variability necessitates individualized treatment approaches.
  • Specific drug properties are critical for successful hypertension control in this age group.

Conclusions:

  • Antihypertensive therapy in the elderly requires careful consideration of patient-specific factors.
  • Medications with convenient dosing, minimal side effects, and ability to manage comorbidities are preferred.
  • Optimizing hypertension treatment in the elderly is essential for improving cardiovascular outcomes.